Heme oxygenase-1 expression in disease states

• Autorzy: Deshane J. , Wright M. , Agarwal A.
• Języki publikacji: EN

Abstrakty

EN

Heme oxygenase-1 (HO-1) is an enzyme which catalyzes the rate-limiting step in heme degradation resulting in the formation of iron, carbon monoxide and biliverdin, which is subsequently converted to bilirubin by biliverdin reductase. The biological effects exerted by the products of this enzymatic reaction have gained much attention. The anti-oxidant, anti-inflammatory and cytoprotective functions associated with HO-1 are attributable to one or more of its degradation products. Induction of HO-1 occurs as an adaptive and beneficial response to several injurious stimuli including heme and this inducible nature of HO-1 signifies its importance in several pathophysiological disease states. The beneficial role of HO-1 has been implicated in several clinically relevant disease states involving multiple organ systems as well as significant biological processes such as ischemia-reperfusion injury, inflammation/immune dysfunction and transplantation. HO-1 has thus emerged as a key target molecule with therapeutic implications.

Słowa kluczowe

EN

polymorphism; disease; cytoprotection; heme oxygenase-1; enzyme; heme oxygenase; heme

• Wydawca: -
• Czasopismo: Acta Biochimica Polonica
• Rocznik: 2005
• Tom: 52
• Numer: 2
• Opis fizyczny: p.273-284,fig.,ref.

Twórcy

autor

Deshane J.

• University of Alabama at Birmingham, Birmingham, USA

autor

Wright M.

autor

Agarwal A.

Bibliografia

• Abraham NG, Kushida T, Mcclung J, Weiss M, Quan S, Lafaro R, Darzynkiewicz Z, Wolin M (2003) Heme oxygenase-1 aenuates glucose-mediated cell growth arrest and apoptosis in human microvessel endothelial cells. Circ Res 93: 507–514.
• Abraham NG, Rezzani R, Rodella L, Kruger A, Taller D, Li Volti G, Goodman AI, Kappas A (2004) Overexpression of human heme oxygenase-1 aenuates endothelial cell sloughing in experimental diabetes. Am J Physiol Heart Circ Physiol 287: H2468–2477.
• Adin CA, Croker BP, Agarwal A (2005) Protective effects of exogenous bilirubin on ischemia-reperfusion injury in the isolated, perfused rat kidney. Am J Physiol Renal Physiol 288: F778–784.
• Agarwal A, Nick HS (2000) Renal response to tissue injury: lessons from heme oxygenase-1 gene ablation and expression. J Am Soc Nephrol 11: 965–973.
• Agarwal A, Balla J, Alam J, Croa AJ, Nath KA (1995) Induction of heme oxygenase in toxic renal injury: a protective role in cisplatin nephrotoxicity in the rat. Kidney Int 48: 1298–1307.
• Agarwal A, Balla J, Balla G, Croa AJ, Vercelloi GM, Nath KA (1996a) Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am J Physiol 271: F814–823.
• Agarwal A, Kim Y, Matas AJ, Alam J, Nath KA (1996b) Gas-generating systems in acute renal allogra rejection in the rat. Co-induction of heme oxygenase and nitric oxide synthase. Transplantation 61: 93–98.
• Agarwal A, Shiraishi F, Visner GA, Nick HS (1998) Linoleyl hydroperoxide transcriptionally upregulates heme oxygenase-1 gene expression in human renal epithelial and aortic endothelial cells. J Am Soc Nephrol 9: 1990–1997.
• Ahmed A, Rahman M, Zhang X, Acevedo CH, Nijjar S, Rushton I, Bussolati B, St John J (2000) Induction of placental heme oxygenase-1 is protective against TNF alpha-induced cytotoxicity and promotes vessel relaxation. Mol Med 6: 391–409.
• Aizawa T, Ishizaka N, Taguchi J-I, Kimura S, Kurokawa K, Ohno M (1999) Balloon injury does not induce heme oxygenase-1 expression, but administration of hemin inhibits neointimal formation in balloon-injured rat carotid artery. Biochem Biophys Res Commun 261: 302–307.
• Aizawa T, Ishizaka N, Taguchi J, Nagai R, Mori I, Tang SS, Ingelfinger JR, Ohno M (2000) Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension 35: 800–806.
• Akamatsu Y, Haga M, Tyagi S, Yamashita K, Graca-Souza AV, Ollinger R, Czismadia E, May GA, Ifedigbo E, Oerbein LE, Bach FH, Soares MP (2004) Heme oxygenase-1-derived carbon monoxide protects hearts from transplant-associated ischemia reperfusion injury. FASEB J 18: 771–772.
• Alam J, Shibahara S, Smith A (1989) Transcriptional activation of the heme oxygenase gene by heme and cadmium in mouse hepatoma cells. J Biol Chem 264: 6371–6375.
• Alam J, Wicks C, Stewart D, Gong P, Touchard C, Oerbein S, Choi AM, Burow ME, Tou J (2000) Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. J Biol Chem 275: 27694–27702.
• Alcaraz MJ, Habib A, Creminon C, Vicente AM, Lebret M, Levy-Toledano S, Maclouf J (2001) Heme oxygenase-1 induction by nitric oxide in raw 264.7 macrophages is upregulated by a cyclo-oxygenase-2 inhibitor. Biochim Biophys Acta 1526: 13–16.
• Amersi F, Buelow R, Kato H, Ke B, Coito AJ, Shen XD, Zhao D, Zaky J, Melinek J, Lassman CR, Kolls JK, Alam J, Rier T, Volk HD, Farmer DG, Ghobrial RM, Busuil RW, Kupiec-Weglinski JW (1999) Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest 104: 1631–1639.
• Attuwaybi BO, Kozar RA, Moore-Olufemi SD, Sato N, Hassoun HT, Weisbrodt NW, Moore FA (2004) Heme oxygenase-1 induction by hemin protects against gut ischemia/reperfusion injury. J Surg Res 118: 53–57.
• Avihingsanon Y, Ma N, Csizmadia E, Wang C, Pavlakis M, Giraldo M, Strom TB, Soares MP, Ferran C (2002) Expression of protective genes in human renal allogras: a regulatory response to injury associated with gra rejection. Transplantation 73: 1079–1085.
• Barber A, Robson SC, Mya L, Bulmer JN, Lyall F (2001) Heme oxygenase expression in human placenta and placental bed: reduced expression of placenta endothelial HO-2 in preeclampsia and fetal growth restriction. FASEB J 15: 1158–1168.
• Baumgartner-Parzer SM, Wagner L, Peermann M, Grillari J, Gessl A, Waldhausl W (1995) High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 44: 1323–1327.
• Bedard EL, Jiang J, Parry N, Wang H, Liu W, Garcia B, Kim P, Chakrabarti S, Buelow R, Zhong R (2005) Peritransplant treatment with cobalt protoporphyrin aenuates chronic renal allogra rejection. Transpl Int 18: 341–349.
• Beltowski J, Jamroz A, Borkowska E (2004) Heme oxygenase and carbon monoxide in the physiology and pathology of the cardiovascular system]. Postepy Hig Med Dosw (Online) 58: 83–99 (in Polish).
• Berger SP, Hunger M, Yard BA, Schnuelle P, Van Der Woude FJ (2000) Dopamine induces the expression of heme oxygenase-1 by human endothelial cells in vitro. Kidney Int 58: 2314–2319.
• Beschorner R, Adjodah D, Schwab JM, Mielbronn M, Pedal I, Maern R, Schluesener HJ, Meyermann R (2000) Long-term expression of heme oxygenase-1 (Ho-1, HSP-32) following focal cerebral infarctions and traumatic brain injury in humans. Acta Neuropathol (Berl) 100: 377–384.
• Braudeau C, Bouchet D, Tesson L, Iyer S, Remy S, Buelow R, Anegon I, Chauveau C (2004) Induction of longterm cardiac allogra survival by heme oxygenase-1 gene transfer. Gene Ther 11: 701–710.
• Camhi SL, Alam J, Oerbein L, Sylvester SL, Choi AM (1995) Induction of heme oxygenase-1 gene expression by lipopolysaccharide is mediated by AP-1 activation. Am J Respir Cell Mol Biol 13: 387–398.
• Camhi SL, Alam J, Wiegand GW, Chin BY, Choi AM (1998) Transcriptional activation of the HO-1 gene by lipopolysaccharide is mediated by 5’ distal enhancers: role of reactive oxygen intermediates and AP-1. Am J Respir Cell Mol Biol 18: 226–234.
• Chang SH, Garcia J, Melendez JA, Kilberg MS, Agarwal A (2003) Haem oxygenase 1 gene induction by glucose deprivation is mediated by reactive oxygen species via the mitochondrial electron-transport chain. Biochem J 371: 877–885.
• Chang KW, Lee TC, Yeh WI, Chung MY, Liu CJ, Chi LY, Lin SC (2004) Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers. Br J Cancer 91: 1551–1555.
• Chen XL, Kunsch C (2004) Induction of cytoprotective genes through nrf2/antioxidant response element pathway: a new therapeutic approach for the treatment of inflammatory diseases. Curr Pharm Des 10: 879–891.
• Chen GG, Liu ZM, Vlantis AC, Tse GM, Leung BC, Van Hasselt CA (2004) Heme Oxygenase-1 protects against apoptosis induced by tumor necrosis factor-alpha and cycloheximide in papillary thyroid carcinoma cells. J Cell Biochem 92: 1246–1256.
• Choi AM, Alam J (1996) Heme Oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 15: 9–19.
• Christou H, Morita T, Hsieh CM, Koike H, Arkonac B, Perrella MA, Kourembanas S (2000) Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat. Circ Res 86: 1224–1229.
• Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Moerlini R (2000) Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 278: H643–651.
• Cosso L, Maineri EP, Traverso N, Rosao N, Pronzato MA, Coalasso D, Marinari UM, Odei P (2001) Induction of heme oxygenase 1 in liver of spontaneously diabetic rats. Free Radic Res 34: 189–191.
• Curcio F, Ceriello A (1992) Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidants: new insights on the pathophysiological mechanisms of diabetic vascular complications. In vitro Cell Dev Biol 28a: 787–790.
• Cuturi MC, Christoph FA, Woo J, Iyer S, Brouard S, Heslan JM, Pignon P, Soulillou JP, Buelow R (1999) Rdp1258, a new rationally designed immunosuppressive peptide, prolongs allogra survival in rats: analysis of its mechanism of action. Mol Med 5: 820–832.
• Das DK, Maulik N, Engelman RM (2004) Redox regulation of angiotensin II signaling in the heart. J Cell Mol Med 8: 144–152.
• Deininger MH, Meyermann R, Trautmann K, Duffner F, Grote EH, Wickboldt J, Schluesener HJ (2000) Heme oxygenase (HO)-1 expressing macrophages/microglial cells accumulate during oligodendroglioma progression. Brain Res 882: 1–8.
• Deng YM, Wu BJ, Wiing PK, Stocker R (2004) Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1. Circulation 110: 1855–1860.
• Denschlag D, Marculescu R, Unfried G, Hefler LA, Exner M, Hashemi A, Riener E-K, Keck C, Tempfer CB, Wagner O (2004). The size of a microsatellite polymorphism of the haem oxygenase 1 gene is associated with idiopathic recurrent miscarriage. Mol Hum Reprod 10: 211–214.
• Doi K, Akaike T, Fujii S, Tanaka S, Ikebe N, Beppu T, Shibahara S, Ogawa M, Maeda H (1999) Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. Br J Cancer 80: 1945–1954.
• Dong Z, Lavrovsky Y, Venkatachalam MA, Roy AK (2000) Heme oxygenase-1 in tissue pathology: the yin and yang. Am J Pathol 156: 1485–1488.
• Duckers HJ, Boehm M, True AL, Yet SF, San H, Park JL, Clinton Webb R, Lee ME, Nabel GJ, Nabel EG (2001) Heme oxygenase-1 protects against vascular constriction and proliferation. Nat Med 7: 693–698.
• Durante W, Kroll MH, Christodoulides N, Peyton KJ, Schafer AI (1997) Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ Res 80: 557–564.
• Exner M, Minar E, Wagner O, Schillinger M (2004) The role of heme oxygenase-1 promoter polymorphisms in human disease. Free Radic Biol Med 37: 1097–1104.
• Fang J, Sawa T, Akaike T, Akuta T, Sahoo SK, Khaled G, Hamada A, Maeda H (2003) In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor. Cancer Res 63: 3567–3574.
• Fujita T, Toda K, Karimova A, Yan SF, Naka Y, Yet SF, Pinsky DJ (2001) Paradoxical rescue from ischemic lung injury by inhaled carbon monoxide driven by derepression of fibrinolysis. Nat Med 7: 598–604.
• Funk M, Endler G, Schillinger M, Mustafa S, Hsieh K, Exner M, Lalouschek W, Mannhalter C, Wagner O (2004) The effect of a promoter polymorphism in the heme oxygenase-1 gene on the risk of ischaemic cerebrovascular events: the influence of other vascular risk factors. Thromb Res 113: 217–223.
• Furnkranz A, Schober A, Bochkov VN, Bashtrykov P, Kronke G, Kadl A, Binder BR, Weber C, Leitinger N (2005) Oxidized phospholipids trigger atherogenic inflammation in murine arteries. Arterioscler Thromb Vasc Biol 25: 633–638.
• Giugliano D, Ceriello A, Paolisso G (1995) Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metabolism 44: 363–368.
• Goodman AI, Choudhury M, Da Silva JL, Schwartzman ML, Abraham NG (1997) Overexpression of the heme oxygenase gene in renal cell carcinoma. Proc Soc Exp Biol Med 214: 54–61.
• Gorogawa S, Kajimoto Y, Umayahara Y, Kaneto H, Watada H, Kuroda A, Kawamori D, Yasuda T, Matsuhisa M, Yamasaki Y, Hori M (2002) Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes. Diabetes Res Clin Pract 57: 1–10.
• Grosser N, Abate A, Oberle S, Vreman HJ, Dennery PA, Becker JC, Pohle T, Seidman DS, Schroder H (2003) Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem Biophys Res Commun 308: 956–960.
• Grosser N, Erdmann K, Hemmerle A, Berndt G, Hinkelmann U, Smith G, Schroder H (2004a) Rosuvastatin upregulates the antioxidant defense protein heme oxygenase- 1. Biochem Biophys Res Commun 325: 871–876.
• Grosser N, Hemmerle A, Berndt G, Erdmann K, Hinkelmann U, Schurgerc S, Wijayanti N, Immenschuh S, Schroder H (2004b) The antioxidant defense protein heme oxygenase 1 is a novel target for statins in endothelial cells. Free Radic Biol Med 37: 2064–2071.
• Haugen EN, Croa AJ, Nath KA (2000) Angiotensin II induces renal oxidant stress in vivo and heme oxygenase- 1 in vivo and in vitro. Kidney Int 58: 144–152.
• Hayashi K, Haneda M, Koya D, Maeda S, Isshiki K, Kikkawa R (2001) Enhancement of glomerular heme oxygenase- 1 expression in diabetic rats. Diabetes Res Clin Pract 52: 85–96.
• Hayashi S, Omata Y, Sakamoto H, Higashimoto Y, Hara T, Sagara Y, Noguchi M (2004) Characterization of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene 336: 241–250.
• He JQ, Ruan J, Conne JE, Anthonisen NR, Pare PD, Sandford AJ (2002) Antioxidant gene polymorphisms and susceptibility to a rapid decline in lung function in smokers. Am J Respir Crit Care Med 166: 323–328.
• Hill-Kapturczak N, Chang SH, Agarwal A (2002) Heme oxygenase and the kidney. DNA Cell Biol 2: 307–321.
• Hill-Kapturczak N, Voakes C, Garcia J, Visner G, Nick HS, Agarwal A (2003) A cis-acting region regulates oxidized lipid-mediated induction of the human heme oxygenase-1 gene in endothelial cells. Arterioscler Thromb Vasc Biol 23: 1416–1422.
• Hoekstra KA, Godin DV, Kurtu J, Cheng KM (2003) Heme Oxygenase and antioxidant status in cultured aortic endothelial cells isolated from atherosclerosis-susceptible and -resistant Japanese quail. Mol Cell Biochem 252: 253–262.
• Holweg CT, Balk AH, Snaathorst J, Van Den Engel S, Niesters HG, Maat AW, Zondervan PE, Weimar W, Baan CC (2004) Intragra heme oxygenase-1 and coronary artery disease aer heart transplantation. Transpl Immunol 13: 265–272.
• Ishii T, Itoh K, Ruiz E, Leake DS, Unoki H, Yamamoto M, Mann GE (2004) Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4- hydroxynonenal. Circ Res 94: 609–616.
• Ishikawa K (2003) Heme oxygenase-1 against vascular insufficiency: roles of atherosclerotic disorders. Curr Pharm Des 9: 2489–2497.
• Ishikawa K, Navab M, Leitinger N, Fogelman AM, Lusis AJ (1997) Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized ldl. J Clin Invest 100: 1209–1216.
• Ishikawa K, Sugawara D, Goto J, Watanabe Y, Kawamura K, Shiomi M, Itabe H, Maruyama Y (2001a) Heme oxygenase- 1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 104: 1831–1836.
• Ishikawa K, Sugawara D, Wang X, Suzuki K, Itabe, H, Maruyama Y, Lusis AJ (2001b). Heme oxygenase-1 inhibits atherosclerotic lesion formation in LDL-receptor knockout mice. Circ Res 88: 506–512.
• Johnson FK, Durante W, Peyton KJ, Johnson RA (2004a) Heme oxygenase-mediated endothelial dysfunction in DOCA-salt, but not in spontaneously hypertensive, rat arterioles. Am J Physiol Heart Circ Physiol 286: H1681–1687.
• Johnson RA, Teran FJ, Durante W, Peyton KJ, Johnson FK (2004b) Enhanced heme oxygenase-mediated coronary vasodilation in Dahl salt-sensitive hypertension. Am J Hypertens 17: 25–30.
• Juan SH, Lee TS, Tseng KW, Liou JY, Shyue SK, Wu KK, Chau LY (2001) Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation 104: 1519–1525.
• Jung NH, Kim HP, Kim BR, Cha SH, Kim GA, Ha H, Na YE, Cha YN (2003) Evidence for heme oxygenase-1 association with caveolin-1 and -2 in mouse mesangial cells. IUBMB Life 55: 525–532.
• Kadoya C, Domino EF, Yang GY, Stern JD, Betz AL (1995) Preischemic but not postischemic zinc protoporphyrin treatment reduces infarct size and edema accumulation aer temporary focal cerebral ischemia in rats. Stroke 26: 1035–1038.
• Kanai M, Tanabe S, Okada M, Suzuki H, Niki T, Katsuura M, Akiba T, Hayasaka K (2003) Polymorphisms of heme oxygenase-1 and bilirubin UDP-glucuronosyl transferase genes are not associated with kawasaki disease susceptibility. Tohoku J Exp Med 200: 155–159.
• Kapitulnik J (2004) Bilirubin: an endogenous product of heme degradation with both cytotoxic and cytoprotective properties. Mol Pharmacol 66: 773–779.
• Kapturczak MH, Wasserfall C, Brusko T, Campbell- Thompson M, Ellis TM, Atkinson MA, Agarwal A (2004) Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1- deficient mouse. Am J Pathol 165: 1045–1053.
• Kato Y, Shimazu M, Kondo M, Uchida K, Kumamoto Y, Wakabayashi G, Kitajima M, Suematsu M (2003) Bilirubin rinse: A simple protectant against the rat liver gra injury mimicking heme oxygenase-1 preconditioning. Hepatology 38: 364–373.
• Ke B, Shen XD, Zhai Y, Gao F, Busuil RW, Volk HD, Kupiec-Weglinski JW (2002) Heme oxygenase 1 mediates the immunomodulatory and antiapoptotic effects of interleukin 13 gene therapy in vivo and in vitro. Hum Gene Ther 13: 1845–1857.
• Keshavan P, Deem TL, Schwemberger SJ, Babcock GF, Cook-Mills JM, Zucker SD (2005) Unconjugated bilirubin inhibits vcam-1-mediated transendothelial leukocyte migration. J Immunol 174: 3709–3718.
• Kikuchi A, Yamaya M, Suzuki S, Yasuda H, Kubo H, Nakayama K, Handa M, Sasaki T, Shibahara S, Sekizawa K, Sasaki H (2005) Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism. Hum Genet 1–14.
• Kim HP, Wang X, Galbiati F, Ryter SW, Choi AM (2004) Caveolae compartmentalization of heme oxygenase-1 in endothelial cells. FASEB J 18: 1080–1089.
• Koya D, Hayashi K, Kitada M, Kashiwagi A, Kikkawa R, Haneda M (2003) Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats. J Am Soc Nephrol 14: S250–253.
• Lang D, Reuter S, Buzescu T, August C, Heidenreich S (2005) Heme-induced heme oxygenase-1 (HO-1) in human monocytes inhibits apoptosis despite caspase-3 up-regulation. Int Immunol 17: 155–165.
• LaRosa JC (2000) Statins and risk of coronary heart disease. JAMA 283: 2935–2936.
• Lash GE, Mclaughlin BE, Macdonald-Goodfellow SK, Smith GN, Brien JF, Marks GS, Nakatsu K, Graham CH (2003) Relationship between tissue damage and heme oxygenase expression in chorionic villi of term human placenta. Am J Physiol Heart Circ Physiol 284: H160–167.
• Lee TS, Chau LY (2002) Heme Oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med 8: 240–246.
• Lee TS, Chang CC, Zhu Y, Shyy JY (2004) Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 110: 1296–1302.
• Liu X, Wei J, Peng DH, Layne MD, Yet SF (2005) Absence of heme oxygenase-1 exacerbates myocardial ischemia/ reperfusion injury in diabetic mice. Diabetes 54: 778–784.
• Liu XM, Chapman GB, Peyton KJ, Schafer AI, Durante W (2002) Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Cardiovasc Res 55: 396–405.
• Lorenzi M, Cagliero E, Toledo S (1985) Glucose toxicity for human endothelial cells in culture. Delayed replication, disturbed cell cycle, and accelerated death. Diabetes 34: 621–627.
• Lorenzi M, Nordberg JA, Toledo S (1987) High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes 36: 1261–1267.
• Lum H, Roebuck KA (2001) Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol 280: C719–741.
• Lyall F, Barber A, Mya L, Bulmer JN, Robson SC (2000) Heme oxygenase expression in human placenta and placental bed implies a role in regulation of trophoblast invasion and placental function. FASEB J 14: 208–219.
• Magee CC, Azuma H, Knoflach A, Denton MD, Chandraker A, Iyer S, Buelow R, Sayegh M (1999) In vitro and in vivo immunomodulatory effects of RDP1258, a novel synthetic peptide. J Am Soc Nephrol 10: 1997–2005.
• Maines MD (1997) The heme oxygenase system: a regulator of second messenger gases. Ann Rev Pharmacol And Toxicol 37: 517–554.
• McCoubrey WK Jr, Huang TJ, Maines MD (1997) Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 247: 725–732.
• Mcfaul SJ, Mcgrath JJ (1987) Studies on the mechanism of carbon monoxide-induced vasodilation in the isolated perfused rat heart. Toxicol Appl Pharmacol 87: 464–473.
• McLaughlin BE, Lash GE, Smith GN, Marks GS, Nakatsu K, Graham CH, Brien JF (2003) Heme oxygenase expression in selected regions of term human placenta. Exp Biol Med (Maywood) 228: 564–567.
• Mohamed AK, Bierhaus A, Schiekofer S, Tritschler H, Ziegler R, Nawroth PP (1999) The role of oxidative stress and NF-κB activation in late diabetic complications. Biofactors 10: 157–167.
• Morisaki H, Katayama T, Kotake Y, Ito M, Handa M, Ikeda Y, Takeda J, Suematsu M (2002) Carbon monoxide modulates endotoxin-induced microvascular leukocyte adhesion through platelet-dependent mechanisms. Anesthesiology 97: 701–709.
• Motterlini R, Gonzales A, Foresti R, Clark JE, Green CJ, Winslow RM (1998) Heme oxygenase-1–derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res 83: 568–577.
• Nakao A, Kimizuka K, Stolz DB, Neto JS, Kaizu T, Choi AM, Uchiyama T, Zuckerbraun BS, Nalesnik MA, Oerbein LE, Murase N (2003) Carbon monoxide inhalation protects rat intestinal gras from ischemia/reperfusion injury. Am J Pathol 163: 1587–1598.
• Nakao A, Neto JS, Kanno S, Stolz DB, Kimizuka K, Liu F, Bach FH, Billiar TR, Choi AM, Oerbein LE, Murase N (2005) Protection against ischemia/reperfusion injury in cardiac and renal transplantation with carbon monoxide, biliverdin and both. Am J Transplant 5: 282–291.
• Nath KA (1999) Heme oxygenase-1: a redoubtable response that limits reperfusion injury in the transplanted adipose liver. J Clin Invest 104: 1485–1486.
• Nath KA, Balla G, Vercelloi GM, Balla J, Jacob HS, Levi MD, Rosenberg ME (1992) Induction of heme oxygenase is a rapid, protective response in rhabdomyolysis in the rat. J Clin Invest 90: 267–270.
• Neto JS, Nakao A, Kimizuka K, Romanosky AJ, Stolz DB, Uchiyama T, Nalesnik MA, Oerbein LE, Murase N (2004) Protection of transplant-induced renal ischemiareperfusion injury with carbon monoxide. Am J Physiol Renal Physiol 287: F979–989.
• Omura S, Suzuki H, Toyofuku M, Ozono R, Kohno N, Igarashi K (2005) Effects of genetic ablation of bach1 upon smooth muscle cell proliferation and atherosclerosis aer cuff injury. Genes Cells 10: 277–285.
• Otterbein LE, Kolls JK, Mantell LL, Cook JL, Alam J, Choi AM (1999a) Exogenous administration of heme oxygenase- 1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 103: 1047–1054.
• Otterbein LE, Mantell LL, Choi AMK (1999b) Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol 276: L688–694.
• Otterbein LE, Soares MP, Yamashita K, Bach FH (2003) Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol 24: 449–455.
• Pachori AS, Melo LG, Hart ML, Noiseux N, Zhang L, Morello F, Solomon SD, Stahl GL, Pra RE, Dzau VJ (2004) Hypoxia-regulated therapeutic gene as a preemptive treatment strategy against ischemia/reperfusion tissue injury. Proc Natl Acad Sci USA 101: 12282–12287.
• Pileggi A, Molano RD, Berney T, Caan P, Vizzardelli C, Oliver R, Fraker C, Ricordi C, Pastori RL, Bach FH, Inverardi L (2001) Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function aer transplantation. Diabetes 50: 1983–1991.
• Platt JL, Nath KA (1998) Heme oxygenase: protective gene or trojan horse. Nat Med 4: 1364–1365.
• Poss KD, Tonegawa S (1997a) Heme oxygenase-1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 94: 10919–10924.
• Poss KD, Tonegawa S (1997b) Reduced stress defense in heme oxygenase-1-deficient cells. Proc Natl Acad Sci USA 94: 10925–10930.
• Quan S, Kaminski PM, Yang L, Morita T, Inaba M, Ikehara S, Goodman AI, Wolin MS, Abraham NG (2004) Heme oxygenase-1 prevents superoxide anion-associated endothelial cell sloughing in diabetic rats. Biochem Biophys Res Commun 315: 509–516.
• Ryter SW, Choi AM (2002) Heme oxygenase-1: molecular mechanisms of gene expression in oxygen-related stress. Antioxid Redox Signal 4: 625–632.
• Ryter SW, Oerbein LE (2004) Carbon monoxide in biology and medicine. Bioessays 26: 270–280.
• Sato K, Balla J, Oerbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercelloi G, Choi AM, Bach FH, Soares MP (2001) Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166: 4185–4194.
• Schillinger M, Exner M, Mlekusch W, Domanovits H, Huber K, Mannhalter C, Wagner O, Minar E (2002) Heme oxygenase-1 gene promoter polymorphism is associated with abdominal aortic aneurysm. Thromb Res 106: 131–136.
• Schillinger M, Exner M, Minar E, Mlekusch W, Mullner M, Mannhalter C, Bach FH, Wagner O (2004) Heme oxygenase-1 genotype and restenosis aer balloon angioplasty: a novel vascular protective factor. J Am Coll Cardiol 43: 950–957.
• Shi W, Haberland ME, Jien ML, Shih DM, Lusis AJ (2000) Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation 102: 75–81.
• Shiraishi F, Curtis LM, Truong L, Poss K, Visner GA, Madsen K, Nick HS, Agarwal A (2000) Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol 278: F726–736.
• Sikorski EM, Hock T, Hill-Kapturczak N, Agarwal A (2004) The story so far: molecular regulation of the heme oxygenase- 1 gene in renal injury. Am J Physiol Renal Physiol 286: F425–441.
• Siow RC, Sato H, Mann GE (1999) Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res 41: 385–394.
• Soares MP, Lin Y, Anrather J, Csizmadia E, Takigami K, Sato K, Grey ST, Colvin RB, Choi AM, Poss KD, Bach FH (1998) Expression of heme oxygenase-1 can determine cardiac xenogra survival. Nat Med 4: 1073–1077.
• Soares MP, Seldon MP, Gregoire IP, Vassilevskaia T, Berberat PO, Yu J, Tsui TY, Bach FH (2004) Heme oxygenase- 1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol 172: 3553–3563.
• Souza AI, Felkin LE, Mccormack AM, Holder A, Barton PJ, Banner NR, Rose ML (2005) Sequential expression of three known protective genes in cardiac biopsies aer transplantation. Transplantation 79: 584–590.
• Tanaka S, Akaike T, Fang J, Beppu T, Ogawa M, Tamura F, Miyamoto Y, Maeda H (2003) Antiapoptotic effect of haem oxygenase-1 induced by nitric oxide in experimental solid tumour. Br J Cancer 88: 902–909.
• Taylor JL, Carraway MS, Piantadosi CA (1998) Lung-specific induction of heme oxygenase-1 and hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol 274: L582–590.
• Terry CM, Clikeman JA, Hoidal JR, Callahan KS (1999) TNF-alpha and IL-1alpha induce heme oxygenase-1 via protein kinase C, Ca2+, and phospholipase A2 in endothelial cells. Am J Physiol 276: H1493–1501.
• Tobiasch E, Gunther L, Bach FH (2001) Heme oxygenase-1 protects pancreatic beta cells from apoptosis caused by various stimuli. J Invest Med 49: 566–571.
• Tomaro ML, Batlle AM (2002) Bilirubin: its role in cytoprotection against oxidative stress. Int J Biochem Cell Biol 34: 216–220.
• Tsuchihashi S, Fondevila C, Kupiec-Weglinski JW (2004) Heme oxygenase system in ischemia and reperfusion injury. Ann Transplant 9: 84–87.
• Tsuji MH, Yanagawa T, Iwasa S, Tabuchi K, Onizawa K, Bannai S, Toyooka H, Yoshida H (1999) Heme oxygenase- 1 expression in oral squamous cell carcinoma as involved in lymph node metastasis. Cancer Le 138: 53–59.
• Tulis DA, Durante W, Liu X, Evans AJ, Peyton KJ, Schafer AI (2001a) Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation 104: 2710–2715.
• Tulis DA, Durante W, Peyton KJ, Evans AJ, Schafer AI (2001b) Heme oxygenase-1 aenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis 155: 113–122.
• Vaughan CJ, Goo AM Jr, Basson CT (2000) The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol 35: 1–10.
• Visner GA, Lu F, Zhou H, Liu J, Kazemfar K, Agarwal A (2003) Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin. Circulation 107: 911–916.
• Vogt BA, Shanley TP, Croa A, Alam J, Johnson KJ, Nath KA (1996) Glomerular inflammation induces resistance to tubular injury in the rat. A novel form of acquired, heme oxygenase-dependent resistance to renal injury. J Clin Invest 98: 2139–2145.
• Wagener Feldman E, de Wie T, Abraham NG (1997) Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc Soc Exp Biol Med 216: 456–463.
• Wagener FA, Da Silva JL, Farley T, De Wie T, Kappas A, Abraham NG (1999) Differential effects of heme oxygenase isoforms on heme mediation of endothelial intracellular adhesion molecule 1 expression. J Pharmacol Exp Ther 291: 416–423.
• Wagener FA, Volk HD, Willis D, Abraham NG, Soares MP, Adema GJ, Figdor CG (2003) Different faces of the heme-heme oxygenase system in inflammation. Pharmacol Rev 55: 551–571.
• Wang YP, Yu YH (2002) Expression of endogenous heme oxygenase on surface of placental trophoblasts of pregnant women with intrauterine growth retardation of the fetus. Di Yi Jun Yi Da Xue Xue Bao 22: 637–639.
• Wang LJ, Lee TS, Lee FY, Pai RC, Chau LY (1998) Expression of heme oxygenase-1 in atherosclerotic lesions. Am J Pathol 152: 711–720.
• Willis D, Moore AR, Frederick R, Willoughby DA (1996) Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat Med 2: 87–90.
• Yachie A, Niida Y, Wada T, Igarashi N, Kaneda H, Toma T, Ohta K, Kasahara Y, Koizumi S (1999) Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103: 129–135.
• Yamada N, Yamaya M, Okinaga S, Nakayama K, Sekizawa K, Shibahara S, Sasaki H (2000) Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am J Hum Genet 66: 187–195.
• Yanagawa T, Omura K, Harada H, Nakaso K, Iwasa S, Koyama Y, Onizawa K, Yusa H, Yoshida H (2004) Heme oxygenase-1 expression predicts cervical lymph node metastasis of tongue squamous cell carcinomas. Oral Oncol 40: 21–27.
• Yang L, Quan S, Nasjlei A, Laniado-Schwartzman M, Abraham NG (2004) Heme oxygenase-1 gene expression modulates angiotensin II-induced increase in blood pressure. Hypertension 43: 1221–1226.
• Yet SF, Pellacani A, Paerson C, Tan L, Folta SC, Foster L, Lee WS, Hsieh CM, Perrella MA (1997) Induction of heme oxygenase-1 expression in vascular smooth muscle cells. A link to endotoxic shock. J Biol Chem 272: 4295–4301.
• Yet SF, Layne MD, Liu X, Chen YH, Ith B, Sibinga NE, Perrella MA (2003) Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J 17: 1759–1761.
• Zampetaki A, Minamino T, Mitsialis SA, Kourembanas S (2003) Effect of heme oxygenase-1 overexpression in two models of lung inflammation. Exp Biol Med 228: 442–446.
• Zhang X, Shan P, Jiang D, Noble PW, Abraham NG, Kappas A, Lee PJ (2004) Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis. J Biol Chem 279: 10677–10684.
• Zhao S, Zhang Y, Gu Y, Lewis DF, Wang Y (2004) Heme Oxygenase-1 mediates up-regulation of adhesion molecule expression induced by peroxynitrite in endothelial cells. J Soc Gynecol Investig 11: 465–471.
• Zou MH, Shi C, Cohen RA (2002) High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/ prostaglandin H2 receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes 51: 198–203.